Literature DB >> 3098192

Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.

P J Maddison, R P Skinner, R S Pereira, C M Black, B M Ansell, M I Jayson, N R Rowell, K I Welsh.   

Abstract

The families of 65 patients with systemic sclerosis were examined clinically and serum samples from each subject were tested for antinuclear antibodies (ANA) by immunofluorescence on HEp2 cells and for precipitating antibodies to soluble cellular antigens including Scl-70. Of 217 blood relatives, 58 (27%) had ANA (42 speckled, 13 nucleolar, one centromere, two homogeneous); 22 (10%) had precipitins, one anti-Scl-70, one anti-PM-Scl, one anti-nRNP, two anti-Ro(SSA), the remainder unidentified). Family members tended to share ANA patterns. Of 38 spouses, nine (24%) had ANA (all speckled) and two showed unidentified precipitins. This compares with an incidence of ANA and precipitins in a control population of 8% and 1% respectively. Antibodies were more common in female than male relatives (particularly in mothers and sisters of probands). Twenty one of the 58 family members with ANA had clinical features of connective tissue disease; the remainder were asymptomatic. The presence of genetic factors influencing autoimmunity is suggested by the incidence of autoantibodies in first degree relatives. Similar observations in spouses, however, indicate that environmental factors may also have a role in these immune abnormalities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098192      PMCID: PMC1001999          DOI: 10.1136/ard.45.10.793

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

1.  Prevalence of disease among vinyl chloride and polyvinyl chloride workers.

Authors:  R Lilis; H Anderson; W J Nicholson; S Daum; A S Fischbein; I J Selikoff
Journal:  Ann N Y Acad Sci       Date:  1975-01-31       Impact factor: 5.691

2.  SCLERODERMA: PERIODONTAL MEMBRANE MANIFESTATIONS IN TWO BROTHERS.

Authors:  R E BLANCHARD; E M SPEED
Journal:  Periodontics       Date:  1965 Mar-Apr

3.  Familial scleroderma.

Authors:  J R Rendall; A W McKenzie
Journal:  Br J Dermatol       Date:  1974-11       Impact factor: 9.302

4.  Scleroderma, immunological and genetic disease in three families.

Authors:  D L Tuffanelli
Journal:  Dermatologica       Date:  1969

5.  "Familial" scleroderma.

Authors:  K M Burge; H O Perry; G B Stickler
Journal:  Arch Dermatol       Date:  1969-06

6.  Familial scleroderma.

Authors:  G M McAndrew; E G Barnes
Journal:  Ann Phys Med       Date:  1965-11

7.  Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies.

Authors:  R J DeHoratius; R Pillarisetty; R P Messner; N Talal
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

8.  Familial progressive systemic scleroderma.

Authors:  R E Greger; R E Greger
Journal:  Arch Dermatol       Date:  1975-01

9.  Progressive systemic sclerosis in a family: case report of a mother and son and review of the literature.

Authors:  R G Gray; R D Altman
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

10.  Genetic polymorphism in human glycine-rich beta-glycoprotein.

Authors:  C A Alper; T Boenisch; L Watson
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 2.  Major histocompatibility complex class II genes and systemic sclerosis.

Authors:  D Briggs; K I Welsh
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.

Authors:  M Jarzabek-Chorzelska; M Blaszczyk; Z Kolacinska-Strasz; T Chorzelski; S Jabłońska; G G Maul
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

4.  HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis.

Authors:  H A Stephens; L I Sakkas; R W Vaughan; I Teitsson; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes.

Authors:  G Rittner; G Schwanitz; M P Baur; C M Black; K I Welsh; P Kühnl; C Rittner
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

6.  Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation.

Authors:  Bing Hao; Song Gao; Yi-Wen Sang; Lin Wang; Xue-Qin Meng; Jing-Ya You
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

7.  Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.

Authors:  Rajpreet K Arora-Singh; Shervin Assassi; Deborah J del Junco; Frank C Arnett; Marilyn Perry; Uzma Irfan; Roozbeh Sharif; Tony Mattar; Maureen D Mayes
Journal:  J Autoimmun       Date:  2010-03-11       Impact factor: 7.094

8.  Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.

Authors:  A J Barnett; L J McNeilage
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

9.  An immunogenetic study of familial scleroderma.

Authors:  M D de Juan; J Belzunegui; I Belmonte; J Barado; M Figueroa; J Cancio; S Vidal; E Cuadrado
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

10.  Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma?

Authors:  Birgitta Kütting; Wolfgang Uter; Hans Drexler
Journal:  J Occup Med Toxicol       Date:  2006-07-03       Impact factor: 2.646

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.